|
 |
 |
 |
Home
> Center Introduction > ¿¬±¸³»¿ë > Chronic hypoxia |
|
|
|
|
| |
| Chronic
hypoxia |
| |
 |
 |
½ÉÇ÷°ü°è¿Í
È£Èí±â°è´Â »ê¼ÒÀÇ Ç×»ó¼º À¯Áö¿¡ ÀÖ¾î Áß¿äÇÑ ±â´ÉÀ» ´ã´çÇÑ´Ù. Àú»ê¼Ò »óÅ¿¡¼ ¼¼Æ÷´Â
¿©·¯ °¡Áö ´Ü¹éµéÀÌ º¯ÈÇÏ¿© »ý¸®ÀûÀÎ Çö»óÀ» ÀÏÀ¸Å°°Ô µÇ´Âµ¥, ¿©±â¿¡´Â hypoxia
inducible factor-1 (HIF-1)¶ó´Â Àü»çÁ¶ÀýÀÎÀÚ°¡ °ü¿©ÇÏ¿© »ý¸®ÀûÀÎ ¹ÝÀÀÀ»
Á¶ÀýÇÑ´Ù°í ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ·¯ÇÑ Áß¿äÇÑ ±â´É ¶§¹®¿¡ Ä¡·áÇÐÀûÀ¸·Îµµ ¸Å¿ì Áß¿äÇÑ Àǹ̸¦
Áö´Ï°í ÀÖ´Ù.
ÇöÀç±îÁö ÁøÇàµÇ¾î ¿Â HIF-1¿¡ ´ëÇÑ ¸¹Àº ¿¬±¸µéÀº HIF-1ÀÌ Àú»ê¼ÒÁõ¿¡ ´ëÇÑ ¼¼Æ÷ÀÇ
ÀÚ°¡Àû ȸº¹À̿ܿ¡µµ ¼¼Æ÷ÀÇ ´ë»ç(metabolism), Áõ½Ä(proliferation),
»ýÁ¸(survival) µî¿¡ °ü¿©ÇÏ´Â À¯ÀüÀÚµéÀÇ È°¼º ¹× Á¶Àý¿¡µµ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù°í
¾Ë·ÁÁ® ÀÖ´Ù. ±× Áß¿¡¼µµ, ÇöÀç ¸¹Àº ¿¬±¸ÀÚµéÀÌ °ü½ÉÀ» °¡Áö°í ¿¬±¸¸¦ Çϰí ÀÖ´Â °ÍÀÌ
Á¾¾ç¿¡ ´ëÇÑ Ä¡·áÀûÀÎ Ãø¸é¿¡¼ÀÇ HIF-1¿¬±¸ÀÌ´Ù. ÇÏÁö¸¸, ÀÌ·¯ÇÑ ¿¬±¸µéÀ» ½Ç½ÃÇϸé¼
ÇöÀç±îÁö ÁøÇàµÇ¾î¿Â ½ÇÇèÀû ¹æ¹ýÀº ¸ðµÎ ÀÏÁ¤ÇÑ ½ÃÁ¡ÀÌ Áö³ µÚ¿¡ ¼¼Æ÷¸¦ Á׿©¼ °üÂûÇÏ´Â
¹æ¹ý(RT-PCR, Western blot, Immunocytochemistry µî)À»
ÅëÇÑ °üÂûÀÌ ÁÖ¸¦ ÀÌ·ç¾î¿Ô´Ù.
ÀÌ·Î ÀÎÇØ, ½ÇÁ¦ÀûÀ¸·Î ¼¼Æ÷ ³»¿¡¼ ÀÌ·ç¾îÁö´Â »ý¸®Àû½ÅÈ£¸¦ ½Ç½Ã°£(real time)À¸·Î
°üÂûÇϰųª ¿¬¼ÓÀûÀÎ ¿øÀΰú °á°ú¸¦ µµÃâÇØ³»´Â µ¥¿¡´Â ±× ÇѰ踦 Áö´Ï°í ÀÖ´Ù. ÀÌ·¯ÇÑ ÇѰèÁ¡
µîÀÌ °á±¹ ÀÓ»ó ¸ðµ¨µ¿¹° ÅëÇÑ ½ÇÇèÀ¸·ÎÀÇ ¹ßÀüÀ» ´õµð°Ô ÇÏ´Â ¿äÀÎÀ̶ó°í ÇÒ ¼ö ÀÖ´Ù. |
 |
|
| |
 |
 |
| º»
¿¬±¸¿¡¼´Â, in vivo¿Í °¡Àå °¡±î¿î ÃÊ´ë¹è¾ç¼¼Æ÷¸¦ ÀÌ¿ëÇÏ¿© Ç¥ÀûÀ¯ÀüÀÚ³ª »ýü½ÅÈ£Àü´Þ¹°ÁúÀ»
¼¼Æ÷ ³»·Î À¯ÀÔ ½ÃÄÑ °¡½ÃÈÇϰí, ¼¼Æ÷°¡ ¿ÜºÎÀڱؿ¡ ´ëÇÏ¿© ¹ÝÀÀÇÏ´Â ½ÅÈ£Àü´ÞÀÇ ÀÏ·ÃÀÇ
°úÁ¤À» ¼¼Æ÷°¡ »ì¾ÆÀÖ´Â »óÅ¿¡¼ °üÂûÇÏ¿©, ±Ã±ØÀûÀ¸·Î´Â Á» ´õ Àӻ󿬱¸¿¡ °¡±î¿î ½ÇÇè¸ðµ¨À»
°³¹ßÇÔÀ¸·Î½á, Àΰ£À¸·ÎÀÇ Ä¡·áÇÐÀû Àû¿ëÀ» ¾Õ´ç±â´Â °ÍÀ» ¸ñÇ¥·Î ÇÑ´Ù. |
 |
|
| |
 |
 |
| Àú»ê¼ÒÁõ »óȲ¿¡¼ HIF-1¿¡
ÀÇÇØ ¸Å°³µÇ´Â ÀÌ¿Âä³ÎÀÇ º¯È¸¦ °üÂûÇÏ°í ±× ±âÀüÀ» ¹àÈ÷±â À§Çؼ ´ÙÀ½°ú °°Àº
´Ü°èÀûÀÎ ½ÇÇèÀýÂ÷¸¦ °ÉÄ£´Ù. |
PRIMARY CELL CULTURE |
µ¿¹°À̳ª »ç¶÷À¸·ÎºÎÅÍ
ºÐ¸®µÈ Ç÷°ü ¹× ½ÉÀå¼¼Æ÷¸¦ ÃÊ´ë¹è¾ç(primary
cell culture) ÇÑ´Ù(±×¸² 1).
°æ¿ì¿¡ µû¶ó¼´Â, °¢ Àå±âÀ¯·¡ÀÇ ¼¼Æ÷ÁÖ
(¿¹, ½ÉÀå: H9c2, Ç÷°ü: BAEC µî)µµ
º´¿ëÇÑ´Ù. |
| |
TRANSFECTION
or VIRAL INFECTION |
Çü±¤ ´Ü¹éÀ̳ª ¹ß»ö¹°ÁúÀ»
À¶ÇÕ ½ÃŲ Ç¥ÀûÀ¯ÀüÀÚ¸¦ À¯ÀüÀÚ µµÀÔ¿ë ½Ã¾à(transfection
reagent)À̳ª ¹ÙÀÌ·¯½ºÀÇ ¼¼Æ÷ ³» ħÀÔÀ»
ÀÀ¿ëÇÑ À¯ÀüÀÚ µµÀÔ¿ë ¹ÙÀÌ·¯½º º¤ÅÍ(viral
vector) µîÀ» ÀÌ¿ëÇÏ¿© ¼¼Æ÷ ³»·Î À¯ÀüÀÚµµÀÔ
ÇÑ´Ù.
- HIF-1alpha¿Í GFP¸¦ À¶ÇÕ(fusion)
½ÃŲ ¹ßÇöº¤ÅÍ(expression vector)¸¦
ÃÊ´ëºÐ¸® ¹è¾çÇÑ ½É±Ù¼¼Æ÷(atrial myocytes)³ª
Ç÷°ü¼¼Æ÷(vesicular smooth muscle
cells or endothelial cells),
ȤÀº ƯÁ¤Àå±âÀ¯·¡ÀÇ ¼¼Æ÷ÁÖ¿¡ |
|
|
|
|
<±×¸²1> Rat atrial myocytesÀÇ primary culture |
|
| ±×¸² 3 Àú»ê¼ÒÁõÀÇ ½Ã°£Àû °æ°ú¿¡ µû¸¥
HIF-1alphaÀÇ ¹ßÇö°ú patch clamping transfection
reagent(¿¹, FuGene6)¸¦ ÀÌ¿ëÇÏ¿© À¯ÀüÀÚµµÀÔÇϰí, G418À»
ÇÔÀ¯ÇÑ ¹èÁö¸¦ ÅëÇØ ¼±Åà ¹è¾çÇÏ¿© ¿øÇÏ´Â ¼¼Æ÷ÁÖ(clones)¸¦
¾ò¾î ³½´Ù. |
 |
| <±×¸²2>
»ê¼ÒÁõ¿¡ ÀÇÇÑ HIF-1alphaÀÇ ¹ßÇö°ú ÇÙ ³»·ÎÀÇ translocation
È®ÀÎ |
| |
 |
| <±×¸²3>
Àú»ê¼ÒÁõÀÇ ½Ã°£Àû °æ°ú¿¡ µû¸¥ HIF-1alphaÀÇ ¹ßÇö°ú patch
clamping |
| |
CHARACTERIZATION |
Imaging systemÀ» ÅëÇÏ¿© Ç¥ÀûÀ¯ÀüÀÚÀÇ
¹ßÇöÀ» È®ÀÎÇϰí, ¿ë¾×ÀÇ Á¶°ÇÀ̳ª ¾à¹°¹ÝÀÀÀ» ÁÖ¾î ÀÌ¿¡ µû¸¥ ¼¼Æ÷
³» ½ÅÈ£ÀÇ º¯È¸¦ ½Ç½Ã°£À¸·Î °üÂûÇÑ´Ù (±×¸²2, 3).
±× ¿¹ºñ °á°ú·Î¼ 4-AP-sensitive K+ currents¸¦
Àú»ê¼ÒÁõÀÇ ½Ã°£Àû °æ°ú¿¡ µû¶ó °üÂûÇÏ¿´´Ù(±×¸² 4).
¿ë¾× ÁßÀÇ »ê¼ÒÀÇ ÇÔ·®À» 1%ÀÌÇÏ·Î ³·Ã߰ųª, HIF-1alphaÀÇ
¼¼Æ÷Áú ³» ºÐÇØ¸¦ Â÷´Ü½ÃŰ´Â ¾à¹°ÀÇ ÀÏÁ¾ÀÎ ciclopirox olamine
(CPX)¸¦ óġÇÏ¿© HIF-1alphaÀÇ ÇÙ ³»·ÎÀÇ À̵¿°ú Ç¥ÀûÀ¯ÀüÀÚ
Àü»çȰ¼º(transcription up-regulation)À» À¯µµÇϰí,
RT-PCRÀ̳ª Ç¥ÀûÀ¯ÀüÀÚ tracing µîÀ» ÅëÇØ HIF-1¿¡
ÀÇÇÑ Ç¥ÀûÀ¯ÀüÀÚ Á¶Àý±âÀüÀ» È®ÀÎÇÑ´Ù. ÀÌ·¯ÇÑ mRNA screeningÀÇ
Ç¥ÀûÀ¯ÀüÀڷμ´Â ¸¸¼º Àú»ê¼ÒÁõ »óȲ¿¡¼ Ȱ¼ºÈµÇ´Â channel
protein, apoptosis ¶Ç´Â Á¾¾çÇü¼º¿¡ °ü¿©ÇÏ´Â Èĺ¸À¯ÀüÀÚ
µîÀ» ±× ´ë»óÀ¸·Î ÇÑ´Ù. |
| |
MODELING
or DEVELOPMENT |
À§ÀÇ ½ÇÇèÀ» ¹ÙÅÁÀ¸·Î in vivo model
(transgenic ¶Ç´Â knock-out/down animal)À»
¼³°è/°³¹ßÇÏ¿© º¸´Ù È¿°úÀûÀ̰í À¯¿ëÇÑ ÀÓ»ó½ÇÇèÀ» ½Ç½ÃÇÑ´Ù.
- Àú»ê¼ÒÁõ¿¡ ´ëÇÏ¿© sensor¿ªÇÒÀ» ´ã´çÇϴ ä³Î´Ü¹éÀ» ¹àÈ÷°í,
À̰ÍÀÇ ±â´ÉÀ» °á¼Õ ½ÃŲ µ¿¹°¸ðµ¨À» °³¹ßÇÏ¿©,
Àú»ê¼Ò¼º Áúȯ¿¡ ´ëÇÑ Ä¡·áÁ¦ÀÇ °³¹ß¿¡ ÀÀ¿ëÇÑ´Ù.
- Á¾¾ç°ú °ü·ÃÇÏ¿© ¼¼Æ÷»ç ±âÀü¿¡ °áÁ¤ÀûÀÎ ¿ªÇÒÀ» ´ã´çÇÏ´Â ¼¼Æ÷
³» moleculeÀÇ ½ÅÈ£Àü´Þ°úÁ¤À» ±Ô¸íÇϰí, ÀÌ·¯ÇÑ
moleculeÀÇ È°¼ºÀ» Á¶ÀýÇÏ´Â À¯ÀüÀÚ¸¦ ¹ÙÅÁÀ¸·Î Á¦ÀÛµÈ ¸ðµ¨µ¿¹°ÀÇ
½ÇÇèÀ» ÅëÇØ Á¾¾çÇü¼º¿¡ ÀúÇ×¼ºÀ» ³ªÅ¸³»´Â À¯ÀüÀû
ÇüÁúÀ» ±Ô¸íÇϰí Á¾¾ç¿¹¹æ ¹× Ä¡·á¿¡ Ȱ¿ëÇÑ´Ù. |
 |
| <±×¸²4>
H9c2 ¼¼Æ÷ÁÖÀÇ Àú»ê¼ÒÁõ¿¡ µû¸¥ 4-AP-sensitive K+
currentsÀÇ ½Ã°£Àû º¯È °üÂû |
|
|
 |
|
| |
 |
 |
 |
Archer
SL, Weir EK, Reeve HL, Michelakis E. Molecular
identification of O©÷ sensors and O©÷-sensitive
potassium channels in the pulmonary circulation.
Adv Exp Med Biol. 2000;475:219-40. Review |
 |
Liu
Y, Gutterman DD. Oxidative stress and potassium
channel function. Clin Exp Pharmacol Physiol.
2002 Apr;29 (4):305-11. Review |
 |
Perez-Garcia
MT, Lopez-Lopez JR. Are Kv channels the essence
of O©÷ sensing? Circ Res. 2000 Mar 17;86(5):490-1.
Review. |
 |
Standen NB, Quayle JM. K+ channel modulation
in arterial smooth muscle. Acta Physiol Scand.
1998 Dec;164 (4):549-57. Review |
 |
Sweeney
M, Yuan JX. Hypoxic pulmonary vasoconstriction:
role of voltage-gated potassium channels.
Respir Res. 2000;1(1):40 -8. Epub 2000 Jul
3. Review |
 |
Yuan XJ, Tod ML, Rubin LJ,
Blaustein MP. Hypoxic and metabolic regulation
of voltage-gated K+ channels in rat pulmonary
artery smooth muscle cells. Exp Physiol. 1995
Sep;80 (5):803-13. Review. |
|
 |
|
|
| |
|
|